Inhibition of enterovirus 71 by adenosine analog NITD008

• Published in: Journal of virology 2014-10, Vol.88 (20), p.11915-11923
• Main Authors: Deng, Cheng-Lin, Yeo, Huimin, Ye, Han-Qing, Liu, Si-Qing, Shang, Bao-Di, Gong, Peng, Alonso, Sylvie, Shi, Pei-Yong, Zhang, Bo
• Format: Article
• Language: English
• Subjects: Adenosine - analogs & derivatives; Adenosine - pharmacology; Animals; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Cercopithecus aethiops; Drug Resistance, Viral - genetics; Enterovirus; Enterovirus A, Human - drug effects; Enterovirus A, Human - growth & development; Enterovirus A, Human - physiology; Enterovirus Infections - drug therapy; Enterovirus Infections - physiopathology; Enterovirus Infections - virology; Flavivirus; Human enterovirus 71; Mice; Mutation; Vaccines and Antiviral Agents; Vero Cells; Viral Load; Viral Plaque Assay; Virus Replication
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/JVI.01207-14

Enterovirus 71 (EV71) is a major viral pathogen in China and Southeast Asia. There is no clinically approved vaccine or antiviral therapy for EV71 infection. NITD008, an adenosine analog, is an inhibitor of flavivirus that blocks viral RNA synthesis. Here we report that NITD008 has potent antiviral activity against EV71. In cell culture, the compound inhibits EV71 at a 50% effective concentration of 0.67 μM and a 50% cytotoxic concentration of 119.97 μM. When administered at 5 mg/kg in an EV71 mouse model, the compound reduced viral loads in various organs and completely prevented clinical symptoms and death. To study the antiviral mechanism and drug resistance, we selected escape mutant viruses by culturing EV71 with increasing concentrations of NITD008. Resistance mutations were reproducibly mapped to the viral 3A and 3D polymerase regions. Resistance analysis with recombinant viruses demonstrated that either a 3A or a 3D mutation alone could lead to resistance to NITD008. A combination of both 3A and 3D mutations conferred higher resistance, suggesting a collaborative interplay between the 3A and 3D proteins during viral replication. The resistance results underline the importance of combination therapy required for EV71 treatment. Importance: Human enterovirus 71 (EV71) has emerged as a major cause of viral encephalitis in children worldwide, especially in the Asia-Pacific region. Vaccines and antivirals are urgently needed to prevent and treat EV71 infections. In this study, we report the in vitro and in vivo efficacy of NITD008 (an adenosine analog) as an inhibitor of EV71. The efficacy results validated the potential of nucleoside analogs as antiviral drugs for EV71 infections. Mechanistically, we showed that mutations in the viral 3A and 3D polymerases alone or in combination could confer resistance to NITD008. The resistance results suggest an intrinsic interaction between viral proteins 3A and 3D during replication, as well as the importance of combination therapy for the treatment of EV71 infections.